相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Saxagliptin enhances osteogenic differentiation in MC3T3-E1 cells, dependent on the activation of AMP-activated protein kinase α (AMPKα)/runt-related transcription factor-2 (Runx-2)
Qiang Wang et al.
BIOENGINEERED (2022)
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
Chenkai Cui et al.
FRONTIERS IN PHARMACOLOGY (2022)
Dipeptidyl peptidase-4 cell surface expression marks an abundant adipose stem/progenitor cell population with high sternness in human white adipose tissue
Florian M. Hatzmann et al.
ADIPOCYTE (2022)
Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review
Barbara Torrecillas-Baena et al.
STEM CELL REVIEWS AND REPORTS (2022)
Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis
Twan J. J. de Winter et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice
Bo Li et al.
VASCULAR PHARMACOLOGY (2021)
High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat Phenotypes
David R. Powell et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis
Haiyu Shao et al.
BIOENGINEERED (2021)
Regulation of Runx2 by post-translational modifications in osteoblast differentiation
K. Gomathi et al.
LIFE SCIENCES (2020)
The protective role of DPP4 inhibitors in atherosclerosis
Hengdao Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Anagliptin stimulates osteoblastic cell differentiation and mineralization
Chao Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Proteasomal degradation induced by DPP9-mediated processing competes with mitochondrial protein import
Yannik Finger et al.
EMBO JOURNAL (2020)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
Carolyn F. Deacon
NATURE REVIEWS ENDOCRINOLOGY (2020)
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases
Ramona Nicotera et al.
PHARMACOLOGICAL RESEARCH (2020)
Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism
Hae Sang Lee et al.
CURRENT DIABETES REPORTS (2020)
DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes
Min Qiu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells
Devika P. Bagchi et al.
MOLECULAR METABOLISM (2020)
Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice
Junkichi Kanda et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Bone disorders associated with diabetes mellitus and its treatments
Bernard Cortet et al.
JOINT BONE SPINE (2019)
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue
David Merrick et al.
SCIENCE (2019)
Effect of sitagliptin on tubulointerstitial Wnt/β-catenin signalling in diabetic nephropathy
Xiaojun Ren et al.
NEPHROLOGY (2019)
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors
Angelo Avogaro et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats
Narattaphol Charoenphandhu et al.
CANADIAN JOURNAL OF DIABETES (2018)
Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer
Yurou Chen et al.
JOURNAL OF GENE MEDICINE (2018)
Diagnosis and management of bone fragility in diabetes: an emerging challenge
S. L. Ferrari et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation
Seung-Yon Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Transcriptomic Analyses of Adipocyte Differentiation From Human Mesenchymal Stromal-Cells (MSC)
Antonio Casado-Diaz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women
H. Kim et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Dipeptidyl peptidase 9 (DPP9) in human skin cells
Jelka Gabrilovac et al.
IMMUNOBIOLOGY (2017)
Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
Yinqiu Yang et al.
FRONTIERS IN PHARMACOLOGY (2017)
DPP9 enzyme activity controls survival of mouse migratory tongue muscle progenitors and its absence leads to neonatal lethality due to suckling defect
Munkyung Kim et al.
DEVELOPMENTAL BIOLOGY (2017)
Diabetes, bone and glucose-lowering agents: clinical outcomes
Ann V. Schwartz
DIABETOLOGIA (2017)
Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration
Thomas H. Ambrosi et al.
CELL STEM CELL (2017)
Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors
Lorenzo Glorie et al.
BONE (2016)
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
C. Klemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes
Yiqian Chen et al.
EXPERIMENTAL CELL RESEARCH (2016)
Microenvironmental Views on Mesenchymal Stem Cell Differentiation in Aging
B. D. Sui et al.
JOURNAL OF DENTAL RESEARCH (2016)
Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes
Pia Zillssen et al.
SCIENTIFIC REPORTS (2016)
Attenuating Hypoxia-Induced Apoptosis and Autophagy of Mesenchymal Stem Cells: the Potential of Sitagliptin in Stem Cell-Based Therapy
Xi-Mei Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis
Hui Zhang et al.
FEBS JOURNAL (2015)
Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance
Tianpeng Zheng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation
Ruijun Han et al.
SCIENTIFIC REPORTS (2015)
Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cellmodel for evaluating the selectivity of DPP4 inhibitors
Yi Huan et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2015)
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
Maria Laura Sbaraglini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth
Hyunjoo Kim et al.
NATURE COMMUNICATIONS (2014)
Stain-Free technology as a normalization tool in Western blot analysis
Anne Guertler et al.
ANALYTICAL BIOCHEMISTRY (2013)
Stain-Free total protein staining is a superior loading control to β-actin for Western blots
Jennifer E. Gilda et al.
ANALYTICAL BIOCHEMISTRY (2013)
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
Jixin Zhong et al.
ATHEROSCLEROSIS (2013)
Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis
Veerle Matheeussen et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Biomineralization Mechanisms: A New Paradigm for Crystal Nucleation in Organic Matrices
Arthur Veis et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Hui Zhang et al.
MOLECULAR CANCER RESEARCH (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells
Chao Shi
IMMUNOLOGY (2012)
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression
Joana Rosmaninho-Salgado et al.
PEPTIDES (2012)
Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients
Mathijs C. Bunck et al.
JOURNAL OF DIABETES (2012)
Developmental Definition of MSCs: New Insights Into Pending Questions
Shishu Huang et al.
CELLULAR REPROGRAMMING (2011)
Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow
Shu-Wen Qian et al.
BMC DEVELOPMENTAL BIOLOGY (2010)
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
Mark Kirby et al.
CLINICAL SCIENCE (2010)
Novel insights into the relationship between diabetes and osteoporosis
Francisco J. A. de Paula et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor
Jia-Jing Wu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis research
A. Casado-Diaz et al.
CYTOTHERAPY (2008)
Dkk1 and Wnt3 interact to control head morphogenesis in the mouse
Samara L. Lewis et al.
DEVELOPMENT (2008)
Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited
B. F. Burkey et al.
DIABETES OBESITY & METABOLISM (2008)
Regulation of bone development and maintenance by Runx2
Toshihisa Komori
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV
Jais R. Bjelke et al.
BIOCHEMICAL JOURNAL (2006)
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9
GR Lankas et al.
DIABETES (2005)
Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV
C Olsen et al.
GENE (2002)
分享论文
